Most Viewed Crystallography Current Events | Crystallography News | 2
|
|
|
Sort By:
Relevance | Date |
RiboTargets joins Partnership for Structural Biology at the European Synchrotron Radiation Facility
RiboTargets, the structure-based drug discovery company that develops novel cancer and anti-bacterial therapeutics, announced today that it has joined the new Partnership for Structural Biology (PSB) established at the European Synchrotron Radiation Facility (ESRF). Associate membership of the PSB will provide guaranteed access to beamlines at... view more... (2003-01-24)
£4 Million for New Centres for Structural Biology
The Biotechnology and Biological Sciences Research Council (BBSRC) today announces its intention to fund four more UK Centres for Structural Biology. view more (1999-02-01)
Complete text of all IUCr journals back to 1948 now online!
The International Union of Crystallography (IUCr) is excited to announce the availability of 50+ years of groundbreaking crystallographic research on your desktop! The complete text of all IUCr journals - back to 1948 - is now online. The IUCr is enabling unprecedented access to its complete journal collection. The Crystallography Journals Online... view more... (2002-02-03)
Discovery about obesity drug helping scientists develop new cancer treatments
Based on their surprising discovery that an obesity drug can kill cancer cells, scientists at Wake Forest University School of Medicine have made a new finding about the drug's effects and are working to design more potent cancer treatments. view more (2007-07-09)
RTS and Syrrx Announce Partnership
RTS Life Science International (RTS) and Syrrx announce a partnership to develop and market high throughput structural biology automation solutions. This will be known as the HTSB Factory™ and it allows the user to set-up hundreds of thousands of experiments for a target and increase the crystallization rate significantly. Dr. Wendell... view more... (2003-05-01)
Structure of key enzyme in plague bacterium found
Researchers at the National Institute of Standards and Technology (NIST) have solved the structure of a key enzyme from the bacterium responsible for plague, finding that it has a highly unusual configuration. The results may shed light both on how the bacterium kills and on fundamental cell signaling processes. view more (2006-08-21)
The structure of a key enzyme for infectious diseases solved at ESRF
A European team of scientists from the University of Dundee (UK), the Technical University of Munich (Germany) and the European Synchrotron Radiation Facility, ESRF, (France) have determined the structure of a key target enzyme for novel drug development to treat infectious diseases including malaria, tuberculosis and sexually transmitted... view more... (2003-08-12)
Best Microchemical Study of an Archeomaterial
Bronze age artifacts, physical links between us and people alive 3000 years ago, have long been closely examined with physics-based instruments such as x-ray crystallography and mass spectrometry. Now scrutiny of microchemical surface properties of such ancient bronze in some respects surpasses the diagnostic information gained by... view more... (2001-09-04)
First structure of transporter enzyme family is solved - Finding will aid drug design to combat depression, stroke and diabetes
Scientists are a step closer to understanding how essential nutrients, vitamins and minerals are ferried into cells. For the first time, a member of the Major Facilitator Superfamily (MFS) of transport proteins, found in almost every form of life, has been visualised by researchers from Imperial College London and the University of California, Los... view more... (2003-07-30)
Potent Peptides Inhibit HIV Entry Into Cells
Based in part on protein structures determined at the National Synchrotron Light Source (NSLS) at the U.S. Department of Energy's Brookhaven National Laboratory, scientists at the University of Utah have developed new peptides that appear to be significantly more effective at blocking HIV's entry into cells than other drugs in their class. view more (2007-10-11)
Researchers Create Model of Cancer-Preventing Enzyme, Study How It Works
Proline dehydrogenase is important because it plays a role in apoptosis, the process of cell death, by enabling the creation of superoxide, a highly reactive electron-rich oxygen species. view more (2007-05-14)
Filming an ultra-fast biological reaction essential to life
A team of scientists from the USA in collaboration with staff at the European Synchrotron Radiation Facility1 (Schotte et al) have managed to film a protein at work in unprecedented detail. The protein is the oxygen-storing molecule myoglobin, which plays a central role in the production of energy in muscles. The motion of the protein was recorded... view more... (2003-06-24)
European researchers launch 10 million Euro collaborative technology project
European researchers launch 10 million Euro collaborative technology project: EMBL-Hamburg coordinates a four-year integrated research project within the 6th Framework Programme of the European Commission: The European Commission has given Europe a huge boost in the field of Structural Genomics, awarding the European Molecular Biology Laboratory... view more... (2004-02-12)
First Look at an Enzyme Target for Antibacterial and Cancer Drugs
The veil has finally been lifted on an enzyme that is critical to the process of DNA transcription and replication, and is a prime target of antibacterial and anticancer drugs. view more (2007-12-21)
IUPUI scientists report first 3-D view of anti-cancer agent
Researchers from the Indiana University School of Medicine and the Purdue School of Science at Indiana University-Purdue University Indianapolis have created the first three-dimensional image of how a well-established chemotherapy agent targets and binds to DNA. view more (2008-03-19)
Chemistry & Industry Magazine - cover date 7 July 2003
NEWS The most toxic conflict Recent advances in the research into Gulf war syndrome means that soldiers returning from the latest conflict may be more fortunate than those returning after 1991. But how much are UK soldiers going to benefit from these advances? The UK spends a lot less than the US on research into the syndrome and unlike UK troops,... view more... (2003-07-03)
Science news from BBSRC
These are just some of the research stories featured in the July 2001 issue of BBSRC business, the community magazine of the Biotechnology and Biological Sciences Research Council. Articles are available in full online at: www.bbsrc.ac.uk/news/features/current.html New chicken vaccine eliminates need for drug intake for broiler chickens A new... view more... (2001-07-02)
Poxvirus Potency Uncovered in New Atomic Map
Scientists at the University of Alabama at Birmingham (UAB) and Saint Louis University used X-ray crystallography to uncover new details about the infectious potency of poxviruses, furthering the understanding of how viral infections can subvert the body's immune system. view more (2008-02-04)
Newly described 'dragon' protein could be key to bird flu cure
Scientists and researchers have taken a big step closer to a cure for the most common strain of avian influenza, or "bird flu," the potential pandemic that has claimed more than 200 lives and infected nearly 400 people in 14 countries since it was identified in 2003. view more (2008-07-16)
Work of Nobel-prize winning scientist Dorothy Hodgkin to be Celebrated with a Landmark Event at Oxford University
The work of the Nobel-prize winning crystallographer, Dorothy Hodgkin (1910-1994), which led to the synthesis of penicillin, vitamin B12 and insulin will be honoured by the Royal Society of Chemistry (RSC) at the University of Oxford on Monday 14 May 2001 through the designation of a National Historical Chemical Landmark. Dorothy Crowfoot Hodgkin... view more... (2001-05-10)
|
|
|
|
Sort By:
Relevance | Date |
|
